Social Media Content Creators Fueling Parallel Trade for Unlicensed Weight-Loss Drug

An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these accounts privately for source information, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a robust trade exists on Telegram, where groups with numerous of members share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors promote the substance there before redirecting customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Voice Worries

Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.

Some professionals said the popularity for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for human use under the British medical regulations.

Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.

Platform Response and Content Removal

According to TikTok, the platform has taken down problematic material and banned related hashtags and search suggestions. The company said it was committed to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Research also found groups with up to nine thousand participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with numerous of users, filled with photos of slimming results, glowing testimonials and step-by-step guides for preparing or administering at residence.

After minutes of entering one community, a seller shared contact information, where the majority of purchases take place. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about body mass, health issues or previous experience.

Product Information and Costs

Inside these groups, posts show dark colored packages with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When asked how much time a injector should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service stated it actively moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Although the research behind this drug is valid, these online versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has already seen individuals injured by self-injection from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may expose users to possibly significant medical dangers”.

Jeremy Tucker
Jeremy Tucker

Maya is a tech journalist and futurist with over a decade of experience covering AI and digital ecosystems.